We’re excited to announce that COVend will be featured at Euroanaesthesia 2025 in Lisbon, taking place from 25–27 May. As one of Europe’s leading events for anaesthesia and intensive care professionals, this year’s congress promises to be both dynamic and insightful — and COVend is proud to be part of it.

We’re excited to announce that COVend will be featured at Euroanaesthesia 2025 in Lisbon, taking place from 25–27 May. As one of Europe’s leading events for anaesthesia and intensive care professionals, this year’s congress promises to be both dynamic and insightful — and COVend is proud to be part of it.

The COVend project is dedicated to developing innovative treatments for COVID-19 and its complications. One of the researchers at the heart of this effort is Zhiran Wang, a PhD student at University College Dublin, whose work focuses on understanding vascular damage in COVID-19 patients and the potential of the FX06 drug candidate.

Unlocking the Potential of FX06: An Interview with the UCD Systems Biology Ireland Team on Their Research in COVend Systems Biology Ireland (SBI), University College Dublin (UCD), focuses on developing

UCD team presenting COVend research results at the European Congress of Immunology 2024 In September 2024, our partners, Zhiran Wang and Günther Eissner from University College Dublin’s Systems Biology Ireland,

COVend featured in the Horizon Europe magazine article “Breathing easier – nature-inspired treatments could relieve acute respiratory distress” We are thrilled to announce that COVend has been featured in a

COVend research presented at 7th European Congress of Immunology in Dublin, 2 September 2024 Our COVend project partner, Zhiran Wang, a researcher from University College Dublin, Systems Biology Ireland, will

COVend presented at Euroanaesthesia 2024 Congress in Munich, May 25-27 On May 25-27, COVend participated in the Euroanaesthesia 2024 Congress in Munich, Germany, organised by our partner, the European Society

COVend partners at EMBL Conference, EMBO Workshop: Building Networks 2024 in Barcelona, Spain The EMBL Conference, EMBO Workshop: Building Networks 2024 took place in Barcelona, Spain on May 6-8, bringing

We are excited to announce the start of patient enrollment for the IXION 2.0 clinical trial at the Goethe University Hospital Frankfurt. Due to the evolving dynamics of COVID-19, the project’s focus has shifted to investigating the potential benefits of the FX06 drug for patients with acute respiratory distress syndrome (ARDS). Spearheaded by Prof. Zacharowski and Dr. Petra Wülfroth, the co-founder of F4 Pharma in Vienna, the consortium and clinical trial were restructured in record time, underlining the unwavering joint commitment to innovative medical research in critical health conditions.

Our COVend consortium member F4 Pharma’s cooperation partners presented groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome (ISCLS), also known as Clarkson disease, first at the 124° Congresso Nazionale of the Societa Italiana di Medicina Interna (SIMI) in October 2023. Now their paper is officially published in Biomedicine & Pharmacotherapy.

On the 13th of November, the consortium member of our partner institution UMCG, Clazinus Veijer, presented his poster “Lessons learned from model-based economic evaluations of COVID-19 treatments under pandemic circumstances: results from a systematic review ” at ISPOR Europe 2023. The poster highlighted results from a systematic review of various methodological characteristics of model-based economic evaluations of COVID-19 treatments.

Exciting research from COVend presented at the joint conference of the Société Française d’Immunologie & Deutsche Gesellschaft für Immunologie in Strasbourg!

COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19 In the ongoing fight against COVID-19, COVend is dedicated to pushing the boundaries of scientific knowledge. Together with

In 2015, the United Nations adopted the 17 Sustainable Development Goals (SDGs) as a global blueprint for addressing pressing challenges. These goals guide our efforts to combat poverty, inequality, climate change, and environmental concerns. Among them, two pivotal goals stand out – SDG 3: Good Health and Well-being, and SDG 9: Industry, Innovation and Infrastructure.

What do an economist, a biochemist, and a clinician have in common? As it turns out, they can all benefit from the latest findings on FX06. The researchers from University College Dublin and the University Medical Center Groningen, the esteemed COVend consortium partners, have revealed new information on FX06 and its potential role in addressing hyperinflammation and capillary leak.

COVend publication: “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” We are thrilled to announce the publication of “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” by our esteemed partners Jan Kloka,

Highway to Health – the future of Healthcare in Europe COVend & ENVISION Cluster and Policy Event On 4 July 2023 the two project consortia of COVend and ENVISION, held

COVend represented at Euroanaesthesia Congress 2023 The COVend partners European Society of Anaesthesiology and Intensive Care (ESAIC), held a successful Euroanaesthesia 2023 (EA23) Congress from 03 June 2023 – 05

HIGHWAY TO HEALTH – EVENT REGISTRATION OPEN Register for our joint COVend & ENVISION Cluster and Policy Event “Highway to Health — Visions in European Healthcare” at the Representation of the State

5th Steering Committee Meeting of COVend Last week, on the 24th of April, 40 consortium members of 11 project partners gathered for one day to hold the fifth Steering Committee

HIGHWAY TO HEALTH – COVend at the ENVISION project final event On the 24th of January, COVend joined the ENVISION project fianl event, Highway to Health in Brussels. As the

COVend, COVIRNA, ENVISION joint webinar “Addressing unmet clinical needs, practices and patient outcomes: the impact of EU-funded projects” On the 5th of January, COVend together with two other EU-funded projects

4th Steering Committee Meeting of COVend On the 10th and 11th of October, the COVend consortium came together in Barcelona to discuss the state of play of the project and

We are happy to announce that after just about a year from the project start, the study protocol of IXION has now been published! Background More than 2.7 million hospitalizations